Efficacy and safety of intraperitoneally administered resveratrol against rat orthotopic ovarian cancers

BACKGROUND: Resveratrol (Res) inhibits ovarian cancer (OC) cell growth but its in vivo anti-OC effects are unclear due to the low bioavailability of systemically administered Res. Intraperitoneal administration may overcome this therapeutic dilemma because it makes Res directly affect the abdominal...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Li-Xia, Wu, Mo-Li, Li, Hong, Liu, Jia, Lin, Li-Zhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620774/
https://www.ncbi.nlm.nih.gov/pubmed/31456648
http://dx.doi.org/10.2147/CMAR.S206301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620774/
https://www.ncbi.nlm.nih.gov/pubmed/31456648
http://dx.doi.org/10.2147/CMAR.S206301

Ejemplares similares